Corcept Therapeutics Incorporated
CORT
Hisse Senetlerindeki Sıralama
#1761
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo... Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable. The company's development pipeline is robust, featuring relacorilant, which is being advanced for Cushing's syndrome. It is also investigating a combination of relacorilant with nab-paclitaxel; this pairing has concluded Phase II clinical trials for advanced ovarian tumors and is additionally being studied for conditions involving cortisol excess. Furthermore, Corcept is developing distinct selective cortisol modulators for specific indications such as metastatic castration-resistant prostate cancer and antipsychotic-induced weight gain, alongside research into FKBP5 gene expression assays.
Hisse Fiyatı
$112.72
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$12.18B
Değişim (1 gün)
2.32%
Değişim (1 yıl)
43.41%
Ülke
US
Ticaret Corcept Therapeutics Incorporated (CORT)
Kategori
Healthcare
Corcept Therapeutics Incorporated (CORT) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 105.38M
Corcept Therapeutics Incorporated şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 105.38M'dir. December 2023 sonunda şirketin 103.56M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Corcept Therapeutics Incorporated (CORT) için 2001 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 105.38M | 2.08% |
| 2024 | 103.23M | -0.32% |
| 2023 | 103.56M | -3.02% |
| 2022 | 106.79M | -7.67% |
| 2021 | 115.65M | 0.21% |
| 2020 | 115.41M | 0.93% |
| 2019 | 114.35M | -9.02% |
| 2018 | 125.68M | 10.71% |
| 2017 | 113.53M | 2.68% |
| 2016 | 110.57M | 3.53% |
| 2015 | 106.80M | 5.77% |
| 2014 | 100.98M | 1.16% |
| 2013 | 99.82M | 7.31% |
| 2012 | 93.02M | 11.65% |
| 2011 | 83.31M | 21.91% |
| 2010 | 68.34M | 30.31% |
| 2009 | 52.44M | 12.25% |
| 2008 | 46.72M | 36.41% |
| 2007 | 34.25M | 49.95% |
| 2006 | 22.84M | 1.03% |
| 2005 | 22.61M | 22.60% |
| 2004 | 18.44M | 113.17% |
| 2003 | 8.65M | 28.73% |
| 2002 | 6.72M | 25.00% |
| 2001 | 5.38M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| 445.06M | 322.35% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 18.05B | 17,027.57% |
HK
|
